Desmond Murphy
National Director - Rare Disease Medical Affairs Lead & MSL Alnylam Pharmaceuticals
Seminars
Wednesday 25th February 2026
Translating Field Insights into Actionable Evidence to Better Inform Clinical Development & Improve Patient Outcomes
4:45 pm
- Identify which questions truly reveal scientific gaps, build awareness and support adoption versus less actionable information
- Which HCPs to engage, how do best identify these individuals
- Learn which interactions are changing minds discover how collected insights can shape protocols, trial design and patient-centric approaches
Wednesday 25th February 2026
Panel: Conversations from the Field – What do MSLs Want You to Know About Their Work
4:00 pm
- Hear what drives MSL activities and what factors make engagements most impactful
- Gain first-hand perspectives from MSLs on the realties of field interactions and the challenges of insight generation
- What activities and points do field teams want senior leadership and stakeholders to be aware of from their work to show their contribution to decision making
